Log in to save to my catalogue

Hepatoma‐derived growth factor is associated with pulmonary vascular remodeling and PAH disease seve...

Hepatoma‐derived growth factor is associated with pulmonary vascular remodeling and PAH disease seve...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f9c608c92ec340fa89eac873ca99df5e

Hepatoma‐derived growth factor is associated with pulmonary vascular remodeling and PAH disease severity and survival

About this item

Full title

Hepatoma‐derived growth factor is associated with pulmonary vascular remodeling and PAH disease severity and survival

Publisher

United States: John Wiley & Sons, Inc

Journal title

Pulmonary circulation, 2022-01, Vol.12 (1), p.e12007-n/a

Language

English

Formats

Publication information

Publisher

United States: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Hepatoma‐derived growth factor (HDGF) was previously shown to be associated with increased mortality in a small study of idiopathic and connective tissue disease‐associated pulmonary arterial hypertension (PAH). In this study, we measured serum HDGF levels in a large multicenter cohort (total 2017 adult PAH‐Biobank enrollees), we analyzed the assoc...

Alternative Titles

Full title

Hepatoma‐derived growth factor is associated with pulmonary vascular remodeling and PAH disease severity and survival

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_f9c608c92ec340fa89eac873ca99df5e

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f9c608c92ec340fa89eac873ca99df5e

Other Identifiers

ISSN

2045-8940,2045-8932

E-ISSN

2045-8940

DOI

10.1002/pul2.12007

How to access this item